And the winner is?
This article was originally published in The Tan Sheet
Executive Summary
Cogene Biotech Ventures CEO Thomas Caskey, MD, and Stanford University School of Medicine cardiology professor Paul Yock, MD, are now being considered as FDA Commissioner candidates by Bush Administration. Strong ties to academia (Caskey taught at Baylor College of Medicine for 25 years) probably is major reason for recent consideration; Senate Health Committee Chairman Edward Kennedy (D-Mass.) discouraged Administration from nominating candidates with ties to industry in a July 13 letter (1"The Tan Sheet" July 23, p. 17)